The Pretoria High Court recently dismissed a pharmaceutical company’s application to review the Department of Health’s (DOH) decision to classify medicines for the purposes of assessing tender bids.
The DOH awarded a tender to supply surfactants to treat Respiratory Distress Syndrome at public hospitals. The tender bid invitation was based on two therapeutic classes